Dr Reddy's Laboratories (DRL) is setting up two special economic zones (SEZs) - one each at Hyderabad and Visakhapatnam in Andhra Pradesh.
Hyderabad SEZ will be exclusively for active pharmaceutical ingredients, the Visakhapatnam SEZ will be for other pharmaceutical products.
The company has a capital expenditure programme of $100 million (over Rs.400 crore) and is expected to continue its geographical expansion and also enhance its growth into oncology and bio-generic products.
Also See:
